Evaluation of SCOUT DS in Subjects With Type 2 Diabetes #2
NCT01346046 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 264
Last updated 2012-12-05
Summary
The primary objective of the trial is to collect SCOUT DS and Hemoglobin A1c measurements of subjects who have been diagnosed with Type 2 diabetes.
Conditions
- Diabetes Mellitus, Non-Insulin Dependent
Sponsors & Collaborators
-
VeraLight, Inc.
lead INDUSTRY
Principal Investigators
-
Walter Forman, MD · Lovelace Scientific Resources
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-05-31
- Primary Completion
- 2011-08-31
- Completion
- 2011-08-31
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of the Effect of Pulsatile Cuts Stendo3 on Vascular Function Patients With Diabetes Type 2
NCT02359461 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Innovated Screening Tools for Type 2 Diabetes Among Chinese Population(SENSIBLE STUDY I)
NCT03025919 ·Status: UNKNOWN
-
Screening and Understanding of the Pre-diabetes: DECODIAB
NCT01739868 ·Status: UNKNOWN ·Phase: NA
-
Endovascular Denervation (EDN) for the Treatment of Type 2 Diabetes Mellitus
NCT05673668 ·Status: UNKNOWN ·Phase: NA
-
Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using CT Angiography, Following Core 64
NCT00488033 ·Status: COMPLETED ·Phase: NA
-
Personalizing A1c Using Hematologic Indices and CGM for Accurate Diabetes Diagnosis
NCT07111416 ·Status: NOT_YET_RECRUITING
-
SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study
NCT05770687 ·Status: RECRUITING
-
Subjects With T2D or at Risk of T2D Cohort Follow-up
NCT05567692 ·Status: SUSPENDED
-
Development of Minimally Invasive Methodology for Diabetyping to Personalise Treatment to Realise Remission and Reversal of Type 2 Diabetes
NCT06125119 ·Status: RECRUITING
-
Clinical Data Collection for the Closed Loop Development for the Type 2 Diabetes Treatment - DT2_1
NCT04522882 ·Status: COMPLETED ·Phase: NA
-
Effect of Iron Reduction by Phlebotomy for Type 2 Diabetes
NCT02468037 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Correlations Between Volatile Organic Compounds and Venous Blood Glucose in Subjects With Type 2 Diabetes
NCT06621030 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
HBA1c and Diagnosis of Type 2 Diabetes
NCT01184768 ·Status: COMPLETED
-
PRimary IndividualiZed Evaluation of Cardiovascular Events in Patients With Diabetes Mellitus Using hemoTAG
NCT06567795 ·Status: RECRUITING
-
Arterial Ablation for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities
NCT05363761 ·Status: RECRUITING ·Phase: PHASE1
-
Carotid Body Function in Type 2 Diabetes Mellitus
NCT05237076 ·Status: COMPLETED ·Phase: NA
-
Diagnosis of Insulin Resistance: 13C-Glucose Breath Test Vs HOMA Index.
NCT00264940 ·Status: UNKNOWN
-
Non-Traditional Cardiovascular Risk Factors in Type 2 Diabetes Mellitus - Ancillary to VA Study of Glycemic Control
NCT00021944 ·Status: COMPLETED
-
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
NCT05219994 ·Status: COMPLETED ·Phase: NA
-
Towards Optimal Screening and Management of Coronary Artery Disease in Diabetes: TOSCANA Study
NCT05314140 ·Status: WITHDRAWN
-
StartRight: Getting the Right Classification and Treatment From Diagnosis in Adults With Diabetes
NCT03737799 ·Status: ACTIVE_NOT_RECRUITING
-
Screening for Undiagnosed Type 2 Diabetes in New Classes of Subjects at High Risk
NCT00520962 ·Status: COMPLETED
-
Evaluation of a Closed-loop System for the Treatment of Type 2 Diabetes at Home (DT2_2)
NCT05369871 ·Status: COMPLETED ·Phase: NA
-
Assessment of SMS and Smartphone Interventions for OneTouch Reveal® Experiences
NCT02429024 ·Status: COMPLETED ·Phase: PHASE4
-
Diabetes Mellitus - A Diagnosis Trial by Means of Non Invasive Measurements
NCT02028091 ·Status: COMPLETED